Qingnan Zhao
Shanghai, 200020, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
LINC01996 suppresses non-small cell lung cancer proliferation and metastasis by orchestrating the miR-12115/CNRIP1/Ras signaling axis.
Journal: Clinical & experimental metastasis
Published: September 19, 2025
Risk factors for drug-related non-infectious pneumonia: insights from the FDA adverse event reporting system (FAERS).
Journal: Expert opinion on drug safety
Published: May 05, 2025
Tree-based ensemble machine learning models in the prediction of acute respiratory distress syndrome following cardiac surgery: a multicenter cohort study.
Journal: Journal of translational medicine
Published: April 23, 2024
The risk factors of diabetic ketosis and diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a retrospective study.
Journal: Expert opinion on drug safety
Published: November 10, 2023
Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3.
Journal: Oncogene
Published: January 22, 2018
Blockade of α7 nicotinic acetylcholine receptors inhibit nicotine-induced tumor growth and vimentin expression in non-small cell lung cancer through MEK/ERK signaling way.
Journal: Oncology reports
Published: December 02, 2016
Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC).
Journal: Cancer biology & therapy
Published: March 18, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026